Curing the Incurable:
The Promises of Gene Editing

Wednesday, February 24, 2021

1 PM PST | 4 PM EST


Your details

Our registration process uses cookies; by submitting this registration form you agree to our cookie policy.

(*) denotes required form field(s)

  Register

Curing the Incurable:
The Promises of Gene Editing

Wednesday, February 24, 2021

1 PM PST | 4 PM EST


Overview

If you've already registered, please click here to log in to the webcast

After decades of lab research, gene editing has emerged as one of the most promising tools in clinical development. More than just therapies, gene editing could enable actual cures for diseases that include cancer and HIV. So, what will it take to realize this promise, and what has yet to be accomplished?

In this virtual event, hosted by Scientific American Custom Media, luminaries in the field will reflect on gene editing’s early days and explore the innovation landscape as a whole, with a focus on developing therapeutics, new disease targets and potential challenges to progress. 

Please join us to learn from some of the most brilliant minds in this rapidly growing area of medicine. A brief audience Q&A will follow the panel.

This event is produced in partnership with Cellectis by Scientific American Custom Media, a division separate from the magazine's board of editors.

Panel

Presenter
George Church, Ph.D.
Robert Winthrop Professor of Genetics
Harvard Medical School
View Biography
Presenter
André Choulika, Ph.D.
CEO
Cellectis
View Biography
Presenter
Matthew Porteus, MD, Ph.D.
Professor
Stanford University School of Medicine
View Biography
Presenter
Dan Ferber, Ph.D.
Senior Editor
Nature Research Custom Media
View Biography